What Researchers Did
Researchers investigated the effectiveness of hyperbaric oxygen therapy in treating a diabetic patient with chronic, ulcerated necrobiosis lipoidica that had been refractory to other treatments.
What They Found
A patient with 7-year duration ulcerated necrobiosis lipoidica, unresponsive to medical and surgical treatments, received daily hyperbaric oxygen therapy. After 98 sessions, the patient experienced considerable improvement, with complete closure of all ulcerations.
What This Means for Canadian Patients
For Canadian patients suffering from chronic, non-healing necrobiosis lipoidica that has failed to respond to conventional therapies, hyperbaric oxygen therapy could represent a viable treatment alternative. This approach offers a potential solution for a difficult-to-treat diabetic complication, possibly enhancing patient outcomes.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
The primary limitation of this study is its design as a single-patient case report, which restricts the generalizability of its findings.